Why is Reata Pharmaceuticals, Inc. (RETA) stock popping high in Pre-Market trading?
Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases, announced that it was communicated from the Division of Neurology Products 1 of the FDA focusing on the preliminary review of briefing materials for an approaching Type C meeting focusing on the development program for omaveloxolone […]
